Quick Takeaways
- UBS Group AG filed SCHEDULE 13G for CLOROX CO /DE/ Common Stock, $1.00 Par Value Per Share (CLX).
- Disclosed ownership: 8.2%.
- Date of event: 31 Dec 2024.
UBS Group AG - 31 Dec 2024 SCHEDULE 13G Report for CLOROX CO /DE/ Common Stock, $1.00 Par Value Per Share (CLX)
- Filing Manager
- UBS Group AG
- Reporting Manager
- UBS Group AG
- Symbol
- CLX
- Shares outstanding
- 122,981,073 shares
- Disclosed Ownership
- 10,084,448 shares
- Ownership
- 8.2%
- Form type
- SCHEDULE 13G
- Filing time
- 25 Apr 2025, 11:41:55 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 25 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"UBS Group AG disclosed 8.2% ownership in CLOROX CO /DE/ Common Stock, $1.00 Par Value Per Share (CLX) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 25 Apr 2025, 11:41.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| UBS Group AG | 8.2% | 10,084,448 | 0 | 237,879 | /s/ Andrew Johnson | Director |